BioGaia Probiotic Cuts Infant Distress Time 43% After Seven Days in Trial

• BioGaia announced November 3, 2026, that a published clinical trial found Protectis Plus BABY reduced infant colic compared with placebo.
• Results appeared in Nutrients on October 22, 2026; the 21-day randomized, double-blind trial enrolled 50 infants, with 48 included in analyses.
• Infant distress declined significantly within seven days, including reduced inconsolable crying; improvements continued throughout the study.
• The dual-strain probiotic drops were well tolerated.
• Protectis Plus BABY has launched in four European markets, with expansion into additional markets planned soon.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioGaia AB published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.